Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trial

Shuang Liu,Xiaojing Lin,Minghao Tao,Qi Chen,Hang Sun,Yali Han,Shaoling Yang,Yining Gao,Shen Qu,Haibing Chen,Shen Qu and Haibing Chen

DOI: https://doi.org/10.1186/s12944-024-02047-7

2024-03-12

Lipids in Health and Disease

Abstract:Obesity is associated with elevated serum uric acid (SUA) levels and frequent gout flares. Losing weight can reduce the SUA level and gout flares. The effect of orlistat on SUA levels and gout flares in patients with overweight/obesity and hyperuricemia (HUA) has not been extensively studied. This study investigated the effects of orlistat on SUA levels and gout flares compared to placebo in overweight and obese patients with HUA.

biochemistry & molecular biology,nutrition & dietetics